Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU2F1-DT (POU2F1 divergent transcript) is a long non-coding RNA transcribed from the POU2F1 locus but on the divergent strand. LncRNAs of this type often regulate neighboring gene expression or participate in chromatin organization[1]. POU2F1-DT is annotated in genomic databases as a non-coding transcript, but its biological function, disease relevance, and druggability have not been established. The scientific and medical literature focuses on the POU2F1 protein (OCT1), a DNA-binding transcription factor involved in gene regulation and cancer biology, rather than the divergent transcript.
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU2F1 divergent transcript (POU2F1-DT).